JHS Svendgaard Laboratories Ltd

JHS Share Price

NSE

₹8.163.77% (-0.32)

Consumer Staples

FMCG - Personal Products

Smallcap

With a market cap of ₹71 cr, stock is ranked 3,375

High Risk

Stock is 4.13x as volatile as Nifty

JHS Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Consumer Staples

FMCG - Personal Products

Smallcap

With a market cap of ₹71 cr, stock is ranked 3,375

High Risk

Stock is 4.13x as volatile as Nifty

JHS Performance & Key Metrics

No LabelNo Label	PB RatioPB Ratio	Dividend YieldDiv. Yield
-13.46	0.41	—

Sector PESector PE	Sector PBSector PB	Sector Div YldSctr Div Yld
32.19	7.87	1.91%

JHS Analyst Ratings & Forecast

—

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

JHS Company Profile

JHS Svendgaard Laboratories Limited offers oral care products (toothbrushes, toothpastes, mouthwash, whitening gels and denture products) for national and global FMCG brands.

JHS Similar Stocks (Peers)

Compare with peers Compare with peers

JHS Similar Stocks (Peers)

Compare with peers Compare with peers

Godrej Consumer Products Ltd

GODREJCP

PE Ratio

57.51

1Y Return

1.06%

Buy Reco %

85.71

Marico Ltd

MARICO

PE Ratio

59.65

1Y Return

23.46%

Buy Reco %

91.18

Dabur India Ltd

DABUR

PE Ratio

46.04

1Y Return

7.26%

Buy Reco %

45.71

Colgate-Palmolive (India) Ltd

COLPAL

PE Ratio

36.74

1Y Return

18.56%

Buy Reco %

36.36

Procter & Gamble Hygiene and Health Care Ltd

PGHH

PE Ratio

51.81

1Y Return

24.75%

Buy Reco %

50.00

Compare with Peers

JHS Forecast

JHS Forecasts

JHS

Income

Balance Sheet

Cash Flow

Financial Year		FY 2017		FY 2018		FY 2019		FY 2020		FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	TTM
Total Revenue	105.49	172.54	130.65	152.95	108.31	95.64	96.13	75.11	94.88	98.32
Raw Materials	35.82	49.85	61.28	73.03	44.05	36.34	33.98	24.85	34.19	98.16
Power & Fuel Cost	3.45	3.42	3.26	3.30	2.98	2.91	2.90	2.73	3.30
Employee Cost	8.66	12.10	13.52	13.44	10.08	11.45	10.19	9.21	10.12
Selling & Administrative Expenses	7.22	9.55	10.26	12.02	4.53	4.70	9.12	4.75	8.63
Operating & Other expenses	38.22	51.65	36.26	46.29	37.21	31.69	56.33	30.20	42.62
EBITDA	12.12	45.97	6.07	4.87	9.46	8.55	-16.39	3.37	-3.98	0.16
Depreciation/Amortization	6.36	6.81	7.09	8.76	7.25	7.05	6.02	6.35	7.95	7.66
PBIT	5.76	39.16	-1.02	-3.89	2.21	1.50	-22.41	-2.98	-11.93	-7.50
Interest & Other Items	0.62	0.74	1.03	1.95	1.24	1.39	0.55	0.46	0.57	0.85
PBT	5.14	38.42	-2.05	-5.84	0.97	0.11	-22.96	-3.44	-12.50	-8.35
Taxes & Other Items	-16.80	12.28	-1.37	-3.87	-0.24	4.16	-27.00	0.63	7.24	-3.05
Net Income	21.94	26.14	-0.68	-1.97	1.21	-4.05	4.04	-4.07	-19.74	-5.30
EPS	5.30	4.91	-0.11	-0.32	0.19	-0.62	0.56	-0.52	-2.41	-0.62
DPS	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout ratio	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

JHS Income Statement

Quarter		sep 2023		dec 2023		mar 2024		jun 2024		sep 2024	dec 2024	mar 2025	jun 2025	sep 2025	dec 2025
Total Revenue	19.13	16.64	23.04	24.80	20.54	22.93	26.60	24.45	23.42	23.85
Operating & Other expenses	18.52	14.36	20.83	22.51	20.53	22.41	33.41	21.79	21.37	21.59
EBITDA	0.61	2.28	2.21	2.29	0.01	0.52	-6.81	2.66	2.05	2.26
Depreciation/Amortization	1.50	1.63	1.90	1.97	1.98	1.97	2.02	1.88	1.86	1.90
PBIT	-0.89	0.65	0.31	0.32	-1.97	-1.45	-8.83	0.78	0.19	0.36
Interest & Other Items	0.10	0.11	0.13	0.12	0.11	0.13	0.21	0.16	0.20	0.28
PBT	-0.99	0.54	0.18	0.20	-2.08	-1.58	-9.04	0.62	-0.01	0.08
Taxes & Other Items	-0.26	0.54	0.93	0.83	8.24	0.25	-2.09	-0.43	0.18	-0.71
Net Income	-0.73	0.00	-0.75	-0.63	-10.32	-1.83	-6.95	1.05	-0.19	0.79
EPS	-0.09	0.00	-0.10	-0.08	-1.24	-0.21	-0.84	0.12	-0.02	0.09

Financial Year		FY 2016		FY 2017		FY 2018		FY 2019		FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025
Cash from Operating Activities	-3.77	-3.93	13.80	-10.79	10.35	12.03	-9.14	23.29	-9.18	-5.18
Cash from Investing Activities	1.48	-3.36	-27.02	-6.87	-10.97	-2.23	-4.70	9.68	-21.14	-20.25
Cash from Financing Activities	4.21	10.11	13.63	12.53	0.49	10.31	-1.67	-0.64	2.17	23.07
Net Change in Cash	+1.92	+2.82	+0.41	-5.13	-0.13	+20.11	-15.51	+32.33	-28.15	-2.36
Changes in Working Capital	-10.67	-14.24	-2.28	-13.91	+2.79	+4.62	-9.43	+23.66	-11.47	-4.54
Capital Expenditures	2.97	12.87	10.84	15.58	10.27	8.33	6.74	14.34	31.53	10.53
Free Cash Flow	-6.74	-16.80	2.96	-26.37	0.08	3.70	-15.88	8.95	-40.71	-15.71

JHS Company Updates

FY 2025FY 2025

Annual report

PDF

FY 2024FY 2024

Annual report

PDF

FY 2023FY 2023

Annual report

PDF

Investor Presentation

May 31PDF

Nov 15PDF

Aug 23PDF

FY 2022FY 2022

Annual report

PDF

Investor Presentation

May 30PDF

Feb 12PDF

Nov 3PDF

Aug 11PDF

FY 2021FY 2021

Annual report

PDF

FY 2020FY 2020

Annual report

PDF

FY 2019FY 2019

Annual report

PDF

FY 2018FY 2018

Annual report

PDF

FY 2017FY 2017

Annual report

PDF

FY 2016FY 2016

Annual report

PDF

JHS Stock Peers

JHS Past Performance & Peer Comparison

Comparing 3 stocks from
Consumer StaplesFMCG - Personal Products

Valuation

Technical

Forecast

Compare valuation on Screener

Stock	PE RatioPE Ratio	PB RatioPB Ratio	Div. YieldDividend Yield
JHS Svendgaard Laboratories Ltd	-3.61	0.41	—
Godrej Consumer Products Ltd	57.51	8.87	2.40%
Marico Ltd	59.65	22.78	1.39%
Dabur India Ltd	46.04	7.26	1.74%

JHS Stock Price Comparison

Compare JHS with any stock or ETF

JHS

JHS Holdings

JHS Shareholdings

JHS Promoter Holdings Trend

JHS Institutional Holdings Trend

No institutional holdings trend are available

JHS Shareholding Pattern

JHS Shareholding History

Foreign Institutions

JHS Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing JHS stock

Looks like this stock is not in any smallcase yet.

JHS Events

JHS Dividend Trend

Dividends

Corp. Actions

Announcements

Legal Orders

JHS Dividend Trend

JHS Dividends

Hmm, looks like data is unavailable here. Please come back after some time

No upcoming corporate actions are available

Demerger

Ex DateEx DateSep 11, 2023

Ratio

—

Ex DateEx Date

Sep 11, 2023

No upcoming announcements are available

Clarification - Financial Results

Announced OnMar 9, 2026

The Exchange has sought clarification fr

Link

—

Announced On

Mar 9, 2026

Copy of Newspaper Publication

Announced OnFeb 12, 2026

JHS Svendgaard Laboratories Limited has

JHS Svendgaard Laboratories Limited has Download

Link

Download

Announced On

Feb 12, 2026

Company Update

Announced OnFeb 12, 2026

JHS Svendgaard Laboratories Ltd - 532771

JHS Svendgaard Laboratories Ltd - 532771 Download

Link

Download

Announced On

Feb 12, 2026

Company Update

Announced OnFeb 10, 2026

JHS Svendgaard Laboratories Ltd - 532771

JHS Svendgaard Laboratories Ltd - 532771 Download

Link

Download

Announced On

Feb 10, 2026

Disclosure of material issue

Announced OnFeb 10, 2026

JHS Svendgaard Laboratories Limited has

JHS Svendgaard Laboratories Limited has Download

Link

Download

Announced On

Feb 10, 2026

JHS Legal Orders

Hmm, looks like data is unavailable here. Please come back after some time

JHS Stock News & Opinions

Earnings

JHS Svendgaard Laboratories reports consolidated net profit of Rs 0.79 crore in the December 2025 quarter

Net profit of JHS Svendgaard Laboratories reported to Rs 0.79 crore in the quarter ended December 2025 as against net loss of Rs 1.84 crore during the previous quarter ended December 2024. Sales rose 2.69% to Rs 23.27 crore in the quarter ended December 2025 as against Rs 22.66 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales23.2722.66 3 OPM %7.181.10 - PBDT1.980.39 408 PBT0.08-1.58 LP NP0.79-1.84 LP Powered by Capital Market - Live

1 month agoCapital Market - Live

Corporate

JHS Svendgaard Laboratories to conduct board meeting

JHS Svendgaard Laboratories will hold a meeting of the Board of Directors of the Company on 10 February 2026.Powered by Capital Market - Live

1 month agoCapital Market - Live

Earnings

JHS Svendgaard Laboratories reports consolidated net loss of Rs 0.20 crore in the September 2025 quarter

Net Loss of JHS Svendgaard Laboratories reported to Rs 0.20 crore in the quarter ended September 2025 as against net loss of Rs 10.32 crore during the previous quarter ended September 2024. Sales rose 13.21% to Rs 22.28 crore in the quarter ended September 2025 as against Rs 19.68 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales22.2819.68 13 OPM %4.08-4.32 - PBDT1.85-0.09 LP PBT-0.02-2.07 99 NP-0.20-10.32 98 Powered by Capital Market - Live

3 months agoCapital Market - Live

Corporate

JHS Svendgaard Laboratories to declare Quarterly Results

JHS Svendgaard Laboratories will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live

4 months agoCapital Market - Live

Corporate

JHS Svendgaard Laboratories revises board meeting date

JHS Svendgaard Laboratories has revised the meeting of the Board of Directors which was scheduled to be held on 13 November 2025. The meeting will now be held on 14 November 2025.Powered by Capital Market - Live

4 months agoCapital Market - Live

Corporate

JHS Svendgaard Laboratories to discuss results

JHS Svendgaard Laboratories will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live

4 months agoCapital Market - Live

Corporate

JHS Svendgaard Laboratories AGM scheduled

JHS Svendgaard Laboratories announced that the Annual General Meeting(AGM) of the company will be held on 20 September 2025.Powered by Capital Market - Live

6 months agoCapital Market - Live

Corporate

JHS Svendgaard Laboratories to convene board meeting

JHS Svendgaard Laboratories will hold a meeting of the Board of Directors of the Company on 21 August 2025.Powered by Capital Market - Live

6 months agoCapital Market - Live

Earnings

JHS Svendgaard Laboratories reports consolidated net profit of Rs 1.06 crore in the June 2025 quarter

Net profit of JHS Svendgaard Laboratories reported to Rs 1.06 crore in the quarter ended June 2025 as against net loss of Rs 0.63 crore during the previous quarter ended June 2024. Sales declined 4.21% to Rs 23.45 crore in the quarter ended June 2025 as against Rs 24.48 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales23.4524.48 -4 OPM %7.088.05 - PBDT2.502.17 15 PBT0.630.20 215 NP1.06-0.63 LP Powered by Capital Market - Live

7 months agoCapital Market - Live

Corporate

JHS Svendgaard Laboratories schedules board meeting

JHS Svendgaard Laboratories will hold a meeting of the Board of Directors of the Company on 12 August 2025.Powered by Capital Market - Live

7 months agoCapital Market - Live

Frequently asked questions

What is the share price of JHS Svendgaard Laboratories Ltd (JHS) today?
The share price of JHS as on 16th March 2026 is ₹8.16. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.
What is the return on JHS Svendgaard Laboratories Ltd (JHS) share?
The past returns of JHS Svendgaard Laboratories Ltd (JHS) share are
- Past 1 week: -8.31%
- Past 1 month: -20.16%
- Past 3 months: -18.64%
- Past 6 months: -27.27%
- Past 1 year: -32%
- Past 3 years: -48.48%
- Past 5 years: -64.13%
What are the peers or stocks similar to JHS Svendgaard Laboratories Ltd (JHS)?
The peers or stocks similar to JHS Svendgaard Laboratories Ltd (JHS) include:
What is the market cap of JHS Svendgaard Laboratories Ltd (JHS) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of JHS Svendgaard Laboratories Ltd (JHS) is ₹71.32 Cr as of 16th March 2026.
What is the 52 week high and low of JHS Svendgaard Laboratories Ltd (JHS) share?
The 52-week high of JHS Svendgaard Laboratories Ltd (JHS) is ₹16.46 and the 52-week low is ₹8.11.
What is the PE and PB ratio of JHS Svendgaard Laboratories Ltd (JHS) stock?
The P/E (price-to-earnings) ratio of JHS Svendgaard Laboratories Ltd (JHS) is -3.61. The P/B (price-to-book) ratio is 0.41.
Which sector does JHS Svendgaard Laboratories Ltd (JHS) belong to?
JHS Svendgaard Laboratories Ltd (JHS) belongs to the Consumer Staples sector & FMCG - Personal Products sub-sector.
How to buy JHS Svendgaard Laboratories Ltd (JHS) shares?
You can directly buy JHS Svendgaard Laboratories Ltd (JHS) shares on Tickertape. Simply sign up, connect your demat account and place your order.

Stock	VolatilityVolatility	RSI–14DRSI – 14D	Price Mom RankPrice Momentum Rank
JHS Svendgaard Laboratories Ltd	51.65%	24.86	Pro
Godrej Consumer Products Ltd	22.47%	20.04
Marico Ltd	19.02%	28.56
Dabur India Ltd	22.01%	26.04

JHS Svendgaard Laboratories Ltd

JHS Share Price

JHS Stock Scorecard

JHS Performance & Key Metrics

JHS Performance & Key Metrics

JHS Analyst Ratings & Forecast

Price Upside

Earnings Growth

Rev. Growth

JHS Company Profile

JHS Similar Stocks (Peers)

JHS Similar Stocks (Peers)

JHS Forecast

JHS Forecasts

JHS